首页 > 最新文献

General Thoracic and Cardiovascular Surgery最新文献

英文 中文
Intraoperative rapid immunohistochemistry of microsatellite instability using non-contact alternating current electric field mixing. 利用非接触式交流电场混合技术对微卫星不稳定性进行术中快速免疫组化。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-23 DOI: 10.1007/s11748-024-02099-7
Kazuhiro Imai, Naoki Yanagawa, Hajime Saito, Hiroshi Nanjo, Yuki Wakamatsu, Shinogu Takashima, Tsubasa Matsuo, Shoji Kuriyama, Tamotsu Sugai, Yoshihiro Minamiya

Objectives: Tumors caused by failure of the DNA-mismatch repair system generally show microsatellite instability (MSI). High-frequency MSI cancers have been shown to be susceptible to immuno-oncology therapies. The aim of this study was to evaluate the clinical reliability of a rapid immunohistochemistry (IHC) technique for intraoperatively assessing molecular status through detection of tumoral deficiencies in the expression of mismatch repair proteins (dMMR; MLH1, MSH2, MSH6, and PMS2).

Methods: The rapid IHC method uses non-contact alternating current (AC) mixing to achieve more rapid/stable staining within a minimum of 13 min during surgery. Sixteen formalin-fixed paraffin-embedded (FFPE) tumor samples from 3 dMMR patients with Lynch syndrome and 6 FFPE samples from 6 dMMR-cancer patients were collected to establish an IHC protocol for MMR proteins. Next, 26 surgical patients treated and whose MSI status was determined using PCR-based tests were retrospectively analyzed. The concordance of dMMR diagnoses for thoracic tumors between the conventional (frozen section (FS)- and FFPE-IHCs) and rapid AC-mixing IHC with FSs were compared.

Results: A rapid IHC protocol using primary antibodies against four MMR proteins (mixed 5-10 min) was established (entire process within 40 min). The concordance rate for MMR-IHC between the conventional and rapid IHC was 100%. dMMR diagnoses including an MSI-high pulmonary sarcoma patient entirely matched between FS- and FFPE-IHC.

Conclusion: Rapid MMR-IHC could potentially serve as a clinical tool for intraoperative determination of tumor MSI/dMMR status. AC-mixing technology will contribute to improving pathological diagnostic capability through the development of an original and innovative rapid IHC.

目的:DNA错配修复系统失效导致的肿瘤通常表现出微卫星不稳定性(MSI)。高频率的 MSI 癌症已被证明易受免疫肿瘤疗法的影响。本研究旨在评估快速免疫组化(IHC)技术的临床可靠性,该技术通过检测肿瘤中错配修复蛋白(dMMR;MLH1、MSH2、MSH6 和 PMS2)的表达缺陷,在术中评估分子状态:快速 IHC 方法采用非接触式交流电(AC)混合法,可在手术过程中至少 13 分钟内实现更快速/稳定的染色。收集了 16 份福尔马林固定石蜡包埋(FFPE)肿瘤样本(来自 3 位林奇综合征 dMMR 患者)和 6 份 FFPE 样本(来自 6 位 dMMR 癌症患者),以制定 MMR 蛋白的 IHC 方案。接着,对 26 例接受过治疗并通过 PCR 检测确定了 MSI 状态的手术患者进行了回顾性分析。比较了传统方法(冰冻切片(FS)和FFPE-IHC)和快速AC-混合IHC与FS的胸部肿瘤dMMR诊断的一致性:结果:使用针对四种MMR蛋白的一抗(混合5-10分钟)建立了快速IHC方案(整个过程在40分钟内完成)。传统 IHC 和快速 IHC 对 MMR-IHC 的吻合率为 100%。包括一名 MSI 高的肺肉瘤患者在内的 MMR 诊断结果与 FS-IHC 和 FFPE-IHC 完全吻合:结论:快速 MMR-IHC 有可能成为术中确定肿瘤 MSI/dMMR 状态的临床工具。AC 混合技术将通过开发一种原始创新的快速 IHC,为提高病理诊断能力做出贡献。
{"title":"Intraoperative rapid immunohistochemistry of microsatellite instability using non-contact alternating current electric field mixing.","authors":"Kazuhiro Imai, Naoki Yanagawa, Hajime Saito, Hiroshi Nanjo, Yuki Wakamatsu, Shinogu Takashima, Tsubasa Matsuo, Shoji Kuriyama, Tamotsu Sugai, Yoshihiro Minamiya","doi":"10.1007/s11748-024-02099-7","DOIUrl":"https://doi.org/10.1007/s11748-024-02099-7","url":null,"abstract":"<p><strong>Objectives: </strong>Tumors caused by failure of the DNA-mismatch repair system generally show microsatellite instability (MSI). High-frequency MSI cancers have been shown to be susceptible to immuno-oncology therapies. The aim of this study was to evaluate the clinical reliability of a rapid immunohistochemistry (IHC) technique for intraoperatively assessing molecular status through detection of tumoral deficiencies in the expression of mismatch repair proteins (dMMR; MLH1, MSH2, MSH6, and PMS2).</p><p><strong>Methods: </strong>The rapid IHC method uses non-contact alternating current (AC) mixing to achieve more rapid/stable staining within a minimum of 13 min during surgery. Sixteen formalin-fixed paraffin-embedded (FFPE) tumor samples from 3 dMMR patients with Lynch syndrome and 6 FFPE samples from 6 dMMR-cancer patients were collected to establish an IHC protocol for MMR proteins. Next, 26 surgical patients treated and whose MSI status was determined using PCR-based tests were retrospectively analyzed. The concordance of dMMR diagnoses for thoracic tumors between the conventional (frozen section (FS)- and FFPE-IHCs) and rapid AC-mixing IHC with FSs were compared.</p><p><strong>Results: </strong>A rapid IHC protocol using primary antibodies against four MMR proteins (mixed 5-10 min) was established (entire process within 40 min). The concordance rate for MMR-IHC between the conventional and rapid IHC was 100%. dMMR diagnoses including an MSI-high pulmonary sarcoma patient entirely matched between FS- and FFPE-IHC.</p><p><strong>Conclusion: </strong>Rapid MMR-IHC could potentially serve as a clinical tool for intraoperative determination of tumor MSI/dMMR status. AC-mixing technology will contribute to improving pathological diagnostic capability through the development of an original and innovative rapid IHC.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142498607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical outcomes of minimally invasive thoracoscopic surgery for pulmonary mycosis complicated with hematopoietic malignancy. 微创胸腔镜手术治疗肺霉菌病并发造血恶性肿瘤的手术效果。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-23 DOI: 10.1007/s11748-024-02092-0
Reo Ohtsuka, Sakashi Fujimori, Souichiro Suzuki, Takahiro Karasaki, Shinichiro Kikunaga, Kazuki Ito, Yosuke Hamada, Shusei Mihara, Otoya Watanabe, Hisashi Yamamoto

Objective: Patients with hematopoietic malignancies (HM) are often immunocompromised and, therefore, susceptible to developing invasive fungal infections, including pulmonary mycosis. Surgical resection is indicated for localized pulmonary mycosis refractory to antifungal agents. This study investigated the feasibility and outcomes of minimally invasive surgery for pulmonary mycosis patients complicated with HM.

Methods: We retrospectively reviewed 56 cases of surgically treated pulmonary mycosis among the 3994 lung resections performed in our department between 2011 and 2020, focusing on the 19 cases under treatment for HM.

Results: All patients underwent 3-port video-assisted thoracoscopic surgery, including one patient converted to open surgery. The 30 day mortality rate was zero. The overall survival rate 1 year after surgery was 63.2%. No relapse of mycosis was observed, and the majority of the cause of death was the progression of HM. The rate of major postoperative complications was comparable between the patients with HM (3/19) and without HM (5/37), despite the patients with HM having a higher frequency of immunocompromised status than those without HM. Most patients who underwent surgery before hematopoietic stem cell transplantation (HSCT) had leukocytopenia, while all patients who underwent surgery after HSCT received immunosuppressants. Mucormycosis was observed in 13 out of 19 patients (68%) with HM, and it was significantly associated with preoperative pancytopenia and usage of immunosuppressants.

Conclusion: Minimally invasive surgery was feasible for pulmonary mycosis complicated with HM despite the high frequency of immunosuppression. These findings will deepen our understanding of pulmonary mycosis associated with HM and may improve perioperative patient care.

目的:造血恶性肿瘤(HM)患者通常免疫力低下,因此容易发生侵袭性真菌感染,包括肺霉菌病。手术切除适用于抗真菌药物难治的局部肺霉菌病。本研究探讨了微创手术治疗并发 HM 的肺霉菌病患者的可行性和效果:我们回顾性分析了 2011 年至 2020 年我科 3994 例肺部切除术中 56 例经手术治疗的肺霉菌病患者,重点研究了 19 例因 HM 而接受治疗的患者:所有患者均接受了3孔视频辅助胸腔镜手术,其中一名患者转为开放手术。30 天死亡率为零。术后 1 年的总生存率为 63.2%。没有观察到霉菌病复发,死亡原因主要是 HM 的进展。有 HM 的患者(3/19)和没有 HM 的患者(5/37)的术后主要并发症发生率相当,尽管有 HM 的患者比没有 HM 的患者有更高的免疫力低下情况。大多数在造血干细胞移植(HSCT)前接受手术的患者白细胞减少,而所有在造血干细胞移植后接受手术的患者都服用了免疫抑制剂。19例HM患者中有13例(68%)观察到粘孢子菌病,这与术前泛白细胞减少和使用免疫抑制剂密切相关:结论:尽管免疫抑制的发生率很高,但微创手术对于肺霉菌病并发 HM 是可行的。这些发现将加深我们对肺霉菌病并发 HM 的认识,并可改善围手术期的患者护理。
{"title":"Surgical outcomes of minimally invasive thoracoscopic surgery for pulmonary mycosis complicated with hematopoietic malignancy.","authors":"Reo Ohtsuka, Sakashi Fujimori, Souichiro Suzuki, Takahiro Karasaki, Shinichiro Kikunaga, Kazuki Ito, Yosuke Hamada, Shusei Mihara, Otoya Watanabe, Hisashi Yamamoto","doi":"10.1007/s11748-024-02092-0","DOIUrl":"https://doi.org/10.1007/s11748-024-02092-0","url":null,"abstract":"<p><strong>Objective: </strong>Patients with hematopoietic malignancies (HM) are often immunocompromised and, therefore, susceptible to developing invasive fungal infections, including pulmonary mycosis. Surgical resection is indicated for localized pulmonary mycosis refractory to antifungal agents. This study investigated the feasibility and outcomes of minimally invasive surgery for pulmonary mycosis patients complicated with HM.</p><p><strong>Methods: </strong>We retrospectively reviewed 56 cases of surgically treated pulmonary mycosis among the 3994 lung resections performed in our department between 2011 and 2020, focusing on the 19 cases under treatment for HM.</p><p><strong>Results: </strong>All patients underwent 3-port video-assisted thoracoscopic surgery, including one patient converted to open surgery. The 30 day mortality rate was zero. The overall survival rate 1 year after surgery was 63.2%. No relapse of mycosis was observed, and the majority of the cause of death was the progression of HM. The rate of major postoperative complications was comparable between the patients with HM (3/19) and without HM (5/37), despite the patients with HM having a higher frequency of immunocompromised status than those without HM. Most patients who underwent surgery before hematopoietic stem cell transplantation (HSCT) had leukocytopenia, while all patients who underwent surgery after HSCT received immunosuppressants. Mucormycosis was observed in 13 out of 19 patients (68%) with HM, and it was significantly associated with preoperative pancytopenia and usage of immunosuppressants.</p><p><strong>Conclusion: </strong>Minimally invasive surgery was feasible for pulmonary mycosis complicated with HM despite the high frequency of immunosuppression. These findings will deepen our understanding of pulmonary mycosis associated with HM and may improve perioperative patient care.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142498610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of transapical-transcatheter aortic valve replacement. 经心尖经导管主动脉瓣置换术的长期疗效。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-23 DOI: 10.1007/s11748-024-02095-x
Koichi Maeda, Kazuo Shimamura, Isamu Mizote, Daisuke Nakamura, Kizuku Yamashita, Ai Kawamura, Daisuke Yoshioka, Yasushi Sakata, Shigeru Miyagawa

Objective: Transapical-transcatheter aortic valve replacement is one of the main interventions indicated for patients where access via peripheral vessels is challenging. However, there have been no reports on the long-term outcomes of this intervention. Here, we report the long-term outcomes of this intervention.

Methods: Among 178 patients who underwent transapical-transcatheter aortic valve replacement between October 2009 and July 2023, 173 patients who underwent this intervention for native aortic stenosis were included in this study, and early and long-term results were evaluated.

Results: The mean age was 82.4 ± 6.4 years, 52.6% were women, mean body area was 1.46 ± 0.17 m2, and the Society of Thoracic Surgeons Predicted Risk of Mortality was 11.2 ± 9.9%. In-hospital mortality was observed in three patients (1.7%). Mean follow-up duration was 4.3 ± 2.8 years, and the survival rates at 1-, 3-, 5-, and 8-years were 84.9%, 67.1%, 47.0%, and 22.1%, respectively. Freedom from cardiovascular mortality at 1, 3, 5, and 8-years was 92.9%, 86.1%, 75.8%, and 53.5%, respectively. The freedom from disabling stroke rates at 1, 3, 5, and 8-years were 95.0%, 92.4%, 92.4%, and 90.8%, respectively. Multivariate analysis revealed that male (Hazard Ratio 1.85, 95%Confidence Interval 1.27-2.70, p = 0.0012) and hemodialysis (Hazard Ratio 1.64, 95%Confidence Interval 1.00-2.67, p = 0.049) were significant poor prognosis factors.

Conclusions: Long-term outcomes of transapical-transcatheter aortic valve replacement were satisfactory. Despite the variety of available approaches, the role of transapical-transcatheter aortic valve replacement, which has low vascular impact, has not been completely lost.

目的:经腹腔镜-经导管主动脉瓣置换术是适用于经外周血管入院有困难的患者的主要介入治疗方法之一。然而,目前还没有关于这种介入治疗的长期疗效的报道。在此,我们报告了这种介入疗法的长期疗效:在 2009 年 10 月至 2023 年 7 月期间接受经心尖-经导管主动脉瓣置换术的 178 例患者中,有 173 例因原发性主动脉瓣狭窄而接受这种介入治疗的患者被纳入本研究,并对早期和长期结果进行了评估:平均年龄为(82.4±6.4)岁,52.6%为女性,平均身体面积为(1.46±0.17)平方米,胸外科医师协会预测的死亡率风险为(11.2±9.9)%。有三名患者(1.7%)出现院内死亡。平均随访时间为 4.3 ± 2.8 年,1、3、5 和 8 年的存活率分别为 84.9%、67.1%、47.0% 和 22.1%。1年、3年、5年和8年的心血管死亡率分别为92.9%、86.1%、75.8%和53.5%。1年、3年、5年和8年免于致残性中风的比例分别为95.0%、92.4%、92.4%和90.8%。多变量分析显示,男性(危险比 1.85,95% 置信区间 1.27-2.70,p = 0.0012)和血液透析(危险比 1.64,95% 置信区间 1.00-2.67,p = 0.049)是显著的不良预后因素:经心尖-经导管主动脉瓣置换术的长期疗效令人满意。结论:经心尖经导管主动脉瓣置换术的长期疗效令人满意。尽管有多种方法可供选择,但对血管影响较小的经心尖经导管主动脉瓣置换术的作用并未完全丧失。
{"title":"Long-term outcomes of transapical-transcatheter aortic valve replacement.","authors":"Koichi Maeda, Kazuo Shimamura, Isamu Mizote, Daisuke Nakamura, Kizuku Yamashita, Ai Kawamura, Daisuke Yoshioka, Yasushi Sakata, Shigeru Miyagawa","doi":"10.1007/s11748-024-02095-x","DOIUrl":"https://doi.org/10.1007/s11748-024-02095-x","url":null,"abstract":"<p><strong>Objective: </strong>Transapical-transcatheter aortic valve replacement is one of the main interventions indicated for patients where access via peripheral vessels is challenging. However, there have been no reports on the long-term outcomes of this intervention. Here, we report the long-term outcomes of this intervention.</p><p><strong>Methods: </strong>Among 178 patients who underwent transapical-transcatheter aortic valve replacement between October 2009 and July 2023, 173 patients who underwent this intervention for native aortic stenosis were included in this study, and early and long-term results were evaluated.</p><p><strong>Results: </strong>The mean age was 82.4 ± 6.4 years, 52.6% were women, mean body area was 1.46 ± 0.17 m<sup>2</sup>, and the Society of Thoracic Surgeons Predicted Risk of Mortality was 11.2 ± 9.9%. In-hospital mortality was observed in three patients (1.7%). Mean follow-up duration was 4.3 ± 2.8 years, and the survival rates at 1-, 3-, 5-, and 8-years were 84.9%, 67.1%, 47.0%, and 22.1%, respectively. Freedom from cardiovascular mortality at 1, 3, 5, and 8-years was 92.9%, 86.1%, 75.8%, and 53.5%, respectively. The freedom from disabling stroke rates at 1, 3, 5, and 8-years were 95.0%, 92.4%, 92.4%, and 90.8%, respectively. Multivariate analysis revealed that male (Hazard Ratio 1.85, 95%Confidence Interval 1.27-2.70, p = 0.0012) and hemodialysis (Hazard Ratio 1.64, 95%Confidence Interval 1.00-2.67, p = 0.049) were significant poor prognosis factors.</p><p><strong>Conclusions: </strong>Long-term outcomes of transapical-transcatheter aortic valve replacement were satisfactory. Despite the variety of available approaches, the role of transapical-transcatheter aortic valve replacement, which has low vascular impact, has not been completely lost.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142498608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risks factors of adverse clinical outcomes in asymptomatic mitral regurgitation patients with preserved ejection fraction: a systematic review and meta-analysis. 射血分数保留的无症状二尖瓣反流患者不良临床结局的风险因素:系统回顾和荟萃分析。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-16 DOI: 10.1007/s11748-024-02094-y
Wilbert Huang, Alvin Frederich, Cynthia Arista, Capella Kezia, Muhammad Irfan Fathoni, Alya Roosrahima Khairunnisa, Lisa Milena Anabela, Siti Shofiah Syahruddin, Samuel Flindy, Alizha Rochana Putri

Introduction and objective: Indication for mitral valve (MV) surgery in asymptomatic mitral regurgitation (MR) patients with preserved ejection fraction (EF) remains unclear. This study aims to identify risk factors of adverse clinical outcomes in asymptomatic MR patients with preserved EF for early indication of MV surgery.

Methods: 3 databases were systematically searched to include studies with asymptomatic MR patients with preserved EF. Risk factors of adverse clinical outcomes (composite outcome of MACE and MV surgery indication), mortality, and left ventricular dysfunction (LVD) are pooled with a meta-analysis of random effect model.

Results: A total of 39 observational studies with 9135 asymptomatic moderate to severe MR patients are included. We identified 21 statistically significant risk factors for adverse outcomes. Increased natriuretic peptide, presence of atrial fibrillation, LV GLS > 20%, LVEDD > 35 mm, LVESD > 22 mm, and LAVI > 55 ml/mm2, ERO > 55mm2, and regurgitation volume > 60 ml (HR 2.21, 2.07, 4.23, 2.98, 4.05, 1.84, 4.02, 3.30, respectively; p-value < 0.05; I2 0-87%) are associated with greater risk of adverse clinical outcome. Risk factors associated with postoperative LVD are the increase of LVEDD, LVESD, and RVSP. Risk factors associated with mortality are increasing STS score and LV GLS.

Conclusion: Several clinical parameters and risk factors can be used to stratify asymptomatic MR patients with preserved ejection fraction who could benefit from early indication for MV surgery.

导言和目的:射血分数(EF)保留的无症状二尖瓣反流(MR)患者的二尖瓣手术指征仍不明确。本研究旨在确定射血分数(EF)保留的无症状二尖瓣反流患者不良临床结局的风险因素,以确定二尖瓣手术的早期指征。采用随机效应模型进行荟萃分析,汇总不良临床结局(MACE和中风手术指征的复合结局)、死亡率和左心室功能障碍(LVD)的风险因素:共纳入 39 项观察性研究,涉及 9135 名无症状的中重度 MR 患者。我们发现了 21 个具有统计学意义的不良后果风险因素。钠尿肽增加、存在心房颤动、左心室GLS > 20%、LVEDD > 35 mm、LVESD > 22 mm、LAVI > 55 ml/mm2、ERO > 55 mm2、反流容积 > 60 ml(HR分别为2.21、2.07、4.23、2.98、4.05、1.84、4.02、3.30;P值为2 0-87%)与不良临床结局的风险增加有关。与术后 LVD 相关的风险因素是 LVEDD、LVESD 和 RVSP 的增加。与死亡率相关的风险因素是STS评分和左心室GLS的增加:结论:一些临床参数和风险因素可用于对射血分数保留的无症状 MR 患者进行分层,这些患者可从早期中风手术指征中获益。
{"title":"Risks factors of adverse clinical outcomes in asymptomatic mitral regurgitation patients with preserved ejection fraction: a systematic review and meta-analysis.","authors":"Wilbert Huang, Alvin Frederich, Cynthia Arista, Capella Kezia, Muhammad Irfan Fathoni, Alya Roosrahima Khairunnisa, Lisa Milena Anabela, Siti Shofiah Syahruddin, Samuel Flindy, Alizha Rochana Putri","doi":"10.1007/s11748-024-02094-y","DOIUrl":"https://doi.org/10.1007/s11748-024-02094-y","url":null,"abstract":"<p><strong>Introduction and objective: </strong>Indication for mitral valve (MV) surgery in asymptomatic mitral regurgitation (MR) patients with preserved ejection fraction (EF) remains unclear. This study aims to identify risk factors of adverse clinical outcomes in asymptomatic MR patients with preserved EF for early indication of MV surgery.</p><p><strong>Methods: </strong>3 databases were systematically searched to include studies with asymptomatic MR patients with preserved EF. Risk factors of adverse clinical outcomes (composite outcome of MACE and MV surgery indication), mortality, and left ventricular dysfunction (LVD) are pooled with a meta-analysis of random effect model.</p><p><strong>Results: </strong>A total of 39 observational studies with 9135 asymptomatic moderate to severe MR patients are included. We identified 21 statistically significant risk factors for adverse outcomes. Increased natriuretic peptide, presence of atrial fibrillation, LV GLS > 20%, LVEDD > 35 mm, LVESD > 22 mm, and LAVI > 55 ml/mm<sup>2</sup>, ERO > 55mm<sup>2</sup>, and regurgitation volume > 60 ml (HR 2.21, 2.07, 4.23, 2.98, 4.05, 1.84, 4.02, 3.30, respectively; p-value < 0.05; I<sup>2</sup> 0-87%) are associated with greater risk of adverse clinical outcome. Risk factors associated with postoperative LVD are the increase of LVEDD, LVESD, and RVSP. Risk factors associated with mortality are increasing STS score and LV GLS.</p><p><strong>Conclusion: </strong>Several clinical parameters and risk factors can be used to stratify asymptomatic MR patients with preserved ejection fraction who could benefit from early indication for MV surgery.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgment to reviewers. 感谢审稿人。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-14 DOI: 10.1007/s11748-024-02091-1
{"title":"Acknowledgment to reviewers.","authors":"","doi":"10.1007/s11748-024-02091-1","DOIUrl":"https://doi.org/10.1007/s11748-024-02091-1","url":null,"abstract":"","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of waitlist weight change on outcomes in heart transplant recipients: a UNOS database analysis. 等待名单体重变化对心脏移植受者预后的影响:UNOS 数据库分析。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-03 DOI: 10.1007/s11748-024-02078-y
Melissa A Austin, Danial Ahmad, Jake L Rosen, Matthew P Weber, Indranee Rajapreyar, Jesus Eduardo Rame, Rene J Alvarez, John W Entwistle, Howard T Massey, Vakhtang Tchantchaleishvili

Background: While the effect of pre-transplant weight on patient outcomes following heart transplantation (HTx) has previously been studied, data regarding the impact of dynamic weight change prior to HTx are extremely limited.

Objectives: We sought to elucidate the interaction between HTx listing weight and weight change while waitlisted, and explore how that interaction impacts post-HTx survival in a continuous manner.

Methods: Adult patients listed for HTx from 1987 to 2020 were identified from UNOS database. Three-dimensional restricted cubic spline analysis explored post-HTx survival relative to both changes in BMI/weight and BMI at time of HTx listing. Continuous predictor variables were analyzed with Cox proportional hazards method.

Results: 9,628 included patients underwent HTx. Median recipient age was 55 [IQR 46-62] years, and 21% were females. 53% of patients lost while 47% gained weight on the waitlist. Median BMI (27.6 kg/m2 [24.3-31.3] vs. 27.4 kg/m2 [24.2-30.9], paired p < 0.001) and weight (84.8 kg [73.0-98.0] kg vs. 84.4 kg [72.6-96.6], p < 0.001) were similar at listing and transplant. One-year survival was 89.3%. Weight loss over 3 BMI points or 10 kg was associated with higher hazard of death irrespective of listing BMI. In non-obese patients, some weight gain (1-4 BMI points or 5-15 kg) was associated with improved survival. In cachectic patients (BMI < 18.5), failure to gain weight was associated with worse survival.

Conclusions: Impact of weight change varies depending on listing BMI. While a survival benefit is seen in non-obese patients who gain some weight, significant weight loss is associated with poorer survival.

背景:虽然移植前体重对心脏移植(HTx)后患者预后的影响已有研究,但有关心脏移植前动态体重变化影响的数据却极为有限:我们试图阐明心脏移植手术前体重与等待期间体重变化之间的相互作用,并探索这种相互作用如何以连续的方式影响心脏移植手术后的存活率:方法:我们从 UNOS 数据库中找到了 1987 年至 2020 年期间列入 HTx 名单的成年患者。三维受限立方样条分析探讨了相对于 BMI/体重变化和 HTx 排期时 BMI 的 HTx 后存活率。连续预测变量采用 Cox 比例危险法进行分析:共有 9628 名患者接受了高温热疗。受术者年龄中位数为 55 [IQR 46-62] 岁,21% 为女性。53%的患者体重减轻,47%的患者体重增加。中位体重指数(27.6 kg/m2 [24.3-31.3] vs. 27.4 kg/m2 [24.2-30.9],配对 p 结论:体重变化的影响因候选名单而异:体重变化的影响因列出的 BMI 而异。体重增加的非肥胖患者可获得生存益处,而体重大幅下降的患者生存率较低。
{"title":"Impact of waitlist weight change on outcomes in heart transplant recipients: a UNOS database analysis.","authors":"Melissa A Austin, Danial Ahmad, Jake L Rosen, Matthew P Weber, Indranee Rajapreyar, Jesus Eduardo Rame, Rene J Alvarez, John W Entwistle, Howard T Massey, Vakhtang Tchantchaleishvili","doi":"10.1007/s11748-024-02078-y","DOIUrl":"https://doi.org/10.1007/s11748-024-02078-y","url":null,"abstract":"<p><strong>Background: </strong>While the effect of pre-transplant weight on patient outcomes following heart transplantation (HTx) has previously been studied, data regarding the impact of dynamic weight change prior to HTx are extremely limited.</p><p><strong>Objectives: </strong>We sought to elucidate the interaction between HTx listing weight and weight change while waitlisted, and explore how that interaction impacts post-HTx survival in a continuous manner.</p><p><strong>Methods: </strong>Adult patients listed for HTx from 1987 to 2020 were identified from UNOS database. Three-dimensional restricted cubic spline analysis explored post-HTx survival relative to both changes in BMI/weight and BMI at time of HTx listing. Continuous predictor variables were analyzed with Cox proportional hazards method.</p><p><strong>Results: </strong>9,628 included patients underwent HTx. Median recipient age was 55 [IQR 46-62] years, and 21% were females. 53% of patients lost while 47% gained weight on the waitlist. Median BMI (27.6 kg/m<sup>2</sup> [24.3-31.3] vs. 27.4 kg/m<sup>2</sup> [24.2-30.9], paired p < 0.001) and weight (84.8 kg [73.0-98.0] kg vs. 84.4 kg [72.6-96.6], p < 0.001) were similar at listing and transplant. One-year survival was 89.3%. Weight loss over 3 BMI points or 10 kg was associated with higher hazard of death irrespective of listing BMI. In non-obese patients, some weight gain (1-4 BMI points or 5-15 kg) was associated with improved survival. In cachectic patients (BMI < 18.5), failure to gain weight was associated with worse survival.</p><p><strong>Conclusions: </strong>Impact of weight change varies depending on listing BMI. While a survival benefit is seen in non-obese patients who gain some weight, significant weight loss is associated with poorer survival.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequential composite BIMA grafting for 3v-CAD: factors that predict successful outcome of the one-inflow and two-inflow revascularization techniques. 针对 3v-CAD 的序列复合 BIMA 移植:预测单流入路和双流入路血管再通技术成功结果的因素。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-03-20 DOI: 10.1007/s11748-024-02022-0
Terézia B Andrási, Alannah C Glück, Ildar Talipov, Lachezar Volevski, Ion Vasiloi

Objective: The effect of one-inflow and two-inflow coronary surgical revascularization techniques inclosing skeletonized double mammary artery (BIMA) as T-graft on outcome is studied.

Methods: Early ad mid-term outcome of complete BIMA revascularization (C-T-BIMA) versus left-sided BIMA with right-sided aorto-coronary bypass (L-T-BIMA + R-CABG) is quantified and analyzed by multivariate logistic regression, Cox-regression, and Kaplan-Meier analysis in a series of 204 consecutive patients treated for triple-vessel coronary disease (3v-CAD).

Results: The L-T-BIMA + R-CABG technique (n = 104) enables higher number of total (4.02 ± 0.87 vs. 3.71 ± 0.69, p = 0.015) and right-sided (1.21 ± 0.43 vs. 1.02 ± 0.32, p = 0.001) coronary anastomoses, improves total bypass flow (125.88 ± 92.41 vs. 82.50 ± 49.26 ml, p < 0.0001) and bypass flow/anastomosis (31.83 ± 23.9 vs.22.77 ± 14.23, p = 0.001), and enhances completeness of revascularization (84% vs.69%, p = 0.014) compared to C-T-BIMA strategy (n = 100), respectively. Although the incidence of MACCE was comparable in the two groups (8% vs.1.2%, p = 0.055), the progression of functional mitral regurgitation (FMR) was significantly lower after L-T-BIMA + R-CABG, then after C-T-BIMA (47% vs.64%, p = 0.017). The use of C-T-BIMA-technique (HR = 4.2, p = 0.01) and preoperative RCA occlusion (HR = 3.006, p = 0.023) predicted FMR progression, whereas L-T-Graft + R-CABG technique protected against it (X2 = 14.04, p < 0.0001) independent of the anatomic and clinical complexity (Syntax score I: HR = 16.2, p = 0.156, Syntax score II: HR = 1.901, p = 0.751), of early- (0.96% vs.2%, p = 0.617) and mid-term mortality (5.8% vs.4%, p = 0.748) when compared to C-T-BIMA, respectively.

Conclusions: The two-inflow coronary revascularization by L-T-BIMA + R-CABG better protects against FMR progression without increasing MACCE and mortality. Older patients with RCA occlusion and reduced LV-EF benefit most from the two-inflow L-T-BIMA + R-CABG technique. Younger 3v-CAD patients with normal LV-EF can preferentially be managed with the one-inflow C-T-BIMA; however, long-term outcome remains to be revealed.

目的研究以镂空双乳动脉(BIMA)作为 T 型移植的单流入路和双流入路冠状动脉外科血管重建技术对疗效的影响:方法:通过多变量逻辑回归、Cox回归和Kaplan-Meier分析,对204例连续接受三血管冠状动脉疾病(3v-CAD)治疗的患者进行量化,并分析完全BIMA血管再通(C-T-BIMA)与左侧BIMA加右侧主动脉旁路(L-T-BIMA + R-CABG)的早期和中期疗效:结果:L-T-BIMA + R-CABG 技术(n = 104)实现了更高的总吻合次数(4.02 ± 0.87 vs. 3.71 ± 0.69,p = 0.015)和右侧吻合次数(1.21 ± 0.43 vs. 1.02 ± 0.32,p = 0.001),改善了旁路总流量(125.88 ± 92.41 vs. 82.50 ± 49.26 ml,p 2 = 14.04,p 结论:L-T-BIMA + R-CABG 技术(n = 104)实现了更高的总吻合次数(4.02 ± 0.87 vs. 3.71 ± 0.69,p = 0.015)和右侧吻合次数(1.21 ± 0.43 vs. 1.02 ± 0.32,p = 0.001):L-T-BIMA+R-CABG的双入路冠状动脉再通术能更好地防止FMR进展,同时不会增加MACCE和死亡率。RCA闭塞和LV-EF降低的老年患者从L-T-BIMA + R-CABG双向血流技术中获益最多。左心室EF正常的年轻3V-CAD患者可优先选择单流入路C-T-BIMA;但长期疗效仍有待观察。
{"title":"Sequential composite BIMA grafting for 3v-CAD: factors that predict successful outcome of the one-inflow and two-inflow revascularization techniques.","authors":"Terézia B Andrási, Alannah C Glück, Ildar Talipov, Lachezar Volevski, Ion Vasiloi","doi":"10.1007/s11748-024-02022-0","DOIUrl":"10.1007/s11748-024-02022-0","url":null,"abstract":"<p><strong>Objective: </strong>The effect of one-inflow and two-inflow coronary surgical revascularization techniques inclosing skeletonized double mammary artery (BIMA) as T-graft on outcome is studied.</p><p><strong>Methods: </strong>Early ad mid-term outcome of complete BIMA revascularization (C-T-BIMA) versus left-sided BIMA with right-sided aorto-coronary bypass (L-T-BIMA + R-CABG) is quantified and analyzed by multivariate logistic regression, Cox-regression, and Kaplan-Meier analysis in a series of 204 consecutive patients treated for triple-vessel coronary disease (3v-CAD).</p><p><strong>Results: </strong>The L-T-BIMA + R-CABG technique (n = 104) enables higher number of total (4.02 ± 0.87 vs. 3.71 ± 0.69, p = 0.015) and right-sided (1.21 ± 0.43 vs. 1.02 ± 0.32, p = 0.001) coronary anastomoses, improves total bypass flow (125.88 ± 92.41 vs. 82.50 ± 49.26 ml, p < 0.0001) and bypass flow/anastomosis (31.83 ± 23.9 vs.22.77 ± 14.23, p = 0.001), and enhances completeness of revascularization (84% vs.69%, p = 0.014) compared to C-T-BIMA strategy (n = 100), respectively. Although the incidence of MACCE was comparable in the two groups (8% vs.1.2%, p = 0.055), the progression of functional mitral regurgitation (FMR) was significantly lower after L-T-BIMA + R-CABG, then after C-T-BIMA (47% vs.64%, p = 0.017). The use of C-T-BIMA-technique (HR = 4.2, p = 0.01) and preoperative RCA occlusion (HR = 3.006, p = 0.023) predicted FMR progression, whereas L-T-Graft + R-CABG technique protected against it (X<sup>2</sup> = 14.04, p < 0.0001) independent of the anatomic and clinical complexity (Syntax score I: HR = 16.2, p = 0.156, Syntax score II: HR = 1.901, p = 0.751), of early- (0.96% vs.2%, p = 0.617) and mid-term mortality (5.8% vs.4%, p = 0.748) when compared to C-T-BIMA, respectively.</p><p><strong>Conclusions: </strong>The two-inflow coronary revascularization by L-T-BIMA + R-CABG better protects against FMR progression without increasing MACCE and mortality. Older patients with RCA occlusion and reduced LV-EF benefit most from the two-inflow L-T-BIMA + R-CABG technique. Younger 3v-CAD patients with normal LV-EF can preferentially be managed with the one-inflow C-T-BIMA; however, long-term outcome remains to be revealed.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"656-667"},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11402859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Right transaxillary transcatheter aortic valve replacement is comparable to left despite challenges. 右侧经腋窝经导管主动脉瓣置换术与左侧相比,尽管存在挑战。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-03-09 DOI: 10.1007/s11748-024-02015-z
Daniel McGrath, Hansuh Lee, Charley Sun, Masashi Kawabori, Yong Zhan

Objectives: Transaxillary access is the most popular alternative to transfemoral transcatheter aortic valve replacement. Although left transaxillary access is generally preferred, right transaxillary transcatheter aortic valve replacement could be challenging because of the opposing axillary artery and aortic curvatures, which may warrant procedural modifications to improve alignment. Our aim is to compare our single center's outcomes for left and right transaxillary access groups and to evaluate procedural modifications for facilitating right transaxillary transcatheter aortic valve replacement.

Methods: Patient characteristics and outcomes were compared for consecutive left or right axillary TAVRs performed from 6/2016 to 6/2022 with SAPIEN 3. The effects of our previously reported "flip-n-flex" technique on procedural efficiency and new conduction disturbances were subanalyzed in the right axillary group.

Results: Right and left transaxillary transcatheter aortic valve replacement were performed in 25 (18 with the "flip-n-flex" technique) and 26 patients, respectively. There were no significant differences between patient characteristics or outcomes. Right axillary subanalysis showed the "flip-n-flex" technique group had significantly shorter fluoroscopy times (21.2 ± 6.2 vs 29.6 ± 12.4 min, p = 0.03) and a trend towards less permanent pacemaker implantation (6.3% vs. 42.9%, p = 0.07) compared to the group without "flip-n-flex".

Conclusions: In our study, despite anatomical challenges, right transaxillary transcatheter aortic valve replacement is comparable to left access. The "flip-n-flex" technique advances right transaxillary as an appealing access for patients with few options.

目的:经腋窝入路是经胸主动脉瓣置换术最常用的替代方法。虽然左侧经腋窝入路通常是首选,但右侧经腋窝经导管主动脉瓣置换术可能具有挑战性,因为腋窝动脉和主动脉曲度相对,可能需要进行程序修改以改善对位。我们的目的是比较我们单个中心左侧和右侧经腋窝入路组的结果,并评估促进右侧经腋窝经导管主动脉瓣置换术的程序修改:比较了2016年6月至2022年6月期间使用SAPIEN 3进行的连续左侧或右侧腋窝TAVR的患者特征和结果。在右腋窝组中,对我们之前报道的 "翻转-n-flex "技术对手术效率和新的传导障碍的影响进行了亚分析:结果:分别有 25 名和 26 名患者接受了右侧和左侧经腋窝经导管主动脉瓣置换术(其中 18 名患者采用了 "翻转-屈曲 "技术)。患者特征和预后无明显差异。右腋窝亚分析显示,与未采用 "翻转-屈曲 "技术的组别相比,"翻转-屈曲 "技术组的透视时间明显缩短(21.2±6.2 vs 29.6±12.4分钟,p = 0.03),永久起搏器植入率也呈下降趋势(6.3% vs 42.9%,p = 0.07):结论:在我们的研究中,尽管存在解剖上的挑战,但右侧经腋窝经导管主动脉瓣置换术与左侧入路的效果相当。翻转-屈曲 "技术将右侧经腋窝作为一种有吸引力的入路,供选择较少的患者使用。
{"title":"Right transaxillary transcatheter aortic valve replacement is comparable to left despite challenges.","authors":"Daniel McGrath, Hansuh Lee, Charley Sun, Masashi Kawabori, Yong Zhan","doi":"10.1007/s11748-024-02015-z","DOIUrl":"10.1007/s11748-024-02015-z","url":null,"abstract":"<p><strong>Objectives: </strong>Transaxillary access is the most popular alternative to transfemoral transcatheter aortic valve replacement. Although left transaxillary access is generally preferred, right transaxillary transcatheter aortic valve replacement could be challenging because of the opposing axillary artery and aortic curvatures, which may warrant procedural modifications to improve alignment. Our aim is to compare our single center's outcomes for left and right transaxillary access groups and to evaluate procedural modifications for facilitating right transaxillary transcatheter aortic valve replacement.</p><p><strong>Methods: </strong>Patient characteristics and outcomes were compared for consecutive left or right axillary TAVRs performed from 6/2016 to 6/2022 with SAPIEN 3. The effects of our previously reported \"flip-n-flex\" technique on procedural efficiency and new conduction disturbances were subanalyzed in the right axillary group.</p><p><strong>Results: </strong>Right and left transaxillary transcatheter aortic valve replacement were performed in 25 (18 with the \"flip-n-flex\" technique) and 26 patients, respectively. There were no significant differences between patient characteristics or outcomes. Right axillary subanalysis showed the \"flip-n-flex\" technique group had significantly shorter fluoroscopy times (21.2 ± 6.2 vs 29.6 ± 12.4 min, p = 0.03) and a trend towards less permanent pacemaker implantation (6.3% vs. 42.9%, p = 0.07) compared to the group without \"flip-n-flex\".</p><p><strong>Conclusions: </strong>In our study, despite anatomical challenges, right transaxillary transcatheter aortic valve replacement is comparable to left access. The \"flip-n-flex\" technique advances right transaxillary as an appealing access for patients with few options.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"641-648"},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140068325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical sealant using free pericardial fat pad with fibrin glue and polyglycolic acid sheets for secondary spontaneous pneumothorax: a novel technique. 使用游离心包脂肪垫与纤维蛋白胶和聚乙二醇酸片进行手术密封治疗继发性自发性气胸:一种新技术。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-06-22 DOI: 10.1007/s11748-024-02050-w
Daisuke Hara, Ryoichi Kondo, Daisuke Nakamura, Kyoko Yamada

We report on the "Triple-FP technique," a novel surgical approach for secondary spontaneous pneumothoraces, which combines a free pericardial fat pad, fibrin glue, and polyglycolic acid sheets. In our experience with 13 patients suffering from secondary spontaneous pneumothoraces, this method effectively prevented postoperative air leaks and re-operations. The technique includes the following steps: (1) harvesting free pericardial fat; (2) suturing around the lung parenchymal defect with the needles and thread left outside the thoracic cavity; (3) ensuring contact between the mediastinal pleural side of the fat and the lung; (4) applying fibrin glue to both the lung and fat before suturing; (5) securing the fat to the lung via the suture thread, reinforced with fibrin glue; and (6) stabilization with polyglycolic acid sheets and additional fibrin glue. This innovative technique is a reliable and effective treatment strategy for secondary spontaneous pneumothoraces, especially for patients with fragile lung tissue.

我们报告的 "三重-FP 技术 "是一种治疗继发性自发性气胸的新型手术方法,它结合了游离心包脂肪垫、纤维蛋白胶和聚乙二醇酸片。在我们对 13 名继发性自发性气胸患者的治疗经验中,这种方法有效地防止了术后漏气和再次手术。该技术包括以下步骤:(1) 采集游离心包脂肪;(2) 用留在胸腔外的针和线缝合肺实质缺损周围;(3) 确保脂肪纵隔胸膜侧与肺部接触;(4) 缝合前在肺部和脂肪上涂抹纤维蛋白胶;(5) 通过缝合线将脂肪固定在肺部,并用纤维蛋白胶加固;(6) 用聚乙二醇酸片和额外的纤维蛋白胶进行稳定。这项创新技术是治疗继发性自发性气胸的可靠而有效的方法,尤其适用于肺组织脆弱的患者。
{"title":"Surgical sealant using free pericardial fat pad with fibrin glue and polyglycolic acid sheets for secondary spontaneous pneumothorax: a novel technique.","authors":"Daisuke Hara, Ryoichi Kondo, Daisuke Nakamura, Kyoko Yamada","doi":"10.1007/s11748-024-02050-w","DOIUrl":"10.1007/s11748-024-02050-w","url":null,"abstract":"<p><p>We report on the \"Triple-FP technique,\" a novel surgical approach for secondary spontaneous pneumothoraces, which combines a free pericardial fat pad, fibrin glue, and polyglycolic acid sheets. In our experience with 13 patients suffering from secondary spontaneous pneumothoraces, this method effectively prevented postoperative air leaks and re-operations. The technique includes the following steps: (1) harvesting free pericardial fat; (2) suturing around the lung parenchymal defect with the needles and thread left outside the thoracic cavity; (3) ensuring contact between the mediastinal pleural side of the fat and the lung; (4) applying fibrin glue to both the lung and fat before suturing; (5) securing the fat to the lung via the suture thread, reinforced with fibrin glue; and (6) stabilization with polyglycolic acid sheets and additional fibrin glue. This innovative technique is a reliable and effective treatment strategy for secondary spontaneous pneumothoraces, especially for patients with fragile lung tissue.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"690-692"},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141436761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A surgical series on endometriosis-related diaphragmatic hernia. 子宫内膜异位症相关膈疝手术系列。
IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-03-10 DOI: 10.1007/s11748-024-02016-y
Antonio Bobbio, Lorenzo Gherzi, Francesco Tormen, Antoine Sion, Mathilde Prieto, Elisa Daffre, Ludovic Fournel, Marco Alifano

Background: Thoracic endometriosis syndrome gives rise to various clinical and radiological manifestations. We reviewed the records of patients operated for intrathoracic migration of abdominal viscera through a diaphragmatic hernia secondary to thoracic endometriosis.

Methods: We retrospectively reviewed the single-center prospective collected database of all patients operated for thoracic endometriosis during the twenty years. All cases in which an abdominal organ was found to be herniated into the thoracic cavity were retrieved. Clinical and pathological data are presented and analyzed.

Results: Twenty women of median age 36 (range 25-58) years were operated for endometriosis-related diaphragmatic hernia. The hernia was diagnosed concomitantly with endometriosis-related pneumothorax in 13 cases and during the exploration of catamenial thoracic pain in seven cases. There were 18 cases on the right side and two cases on the left side. The median diameter of the hernia was 8 cm (2.5-20 cm). In seventeen cases, the hernia was repaired by direct suture, and in three cases a heterologous prosthesis was positioned. At follow-up, two patients had an episode of recurrent pneumothorax.

Conclusions: Diaphragmatic hernia should be ruled out in the presence of endometriosis-related pneumothorax or catamenial thoracic pain. Surgery is indicated to make a pathological diagnosis, restore anatomy, and prevent recurrence in patients presenting with pneumothorax.

背景:胸部子宫内膜异位症综合征有多种临床和影像学表现。我们回顾了因胸部子宫内膜异位症继发腹腔脏器通过膈疝向胸腔内移位而接受手术的患者记录:我们回顾性地查看了单中心前瞻性数据库中收集的 20 年间所有因胸部子宫内膜异位症而接受手术的患者的资料。我们检索了所有发现腹腔器官疝入胸腔的病例。结果:中位年龄为 36 岁(25-58 岁)的 20 名妇女因子宫内膜异位症相关膈疝接受了手术。其中 13 例在子宫内膜异位症相关气胸时被诊断为膈疝,7 例在探查导管性胸痛时被诊断为膈疝。其中右侧 18 例,左侧 2 例。疝气的中位直径为 8 厘米(2.5-20 厘米)。其中 17 例患者的疝气通过直接缝合修复,3 例患者植入了异体假体。在随访中,有两名患者再次出现气胸:结论:如果出现与子宫内膜异位症相关的气胸或胸痛,应排除膈疝的可能。结论:出现子宫内膜异位症相关气胸或胸痛时,应排除膈疝的可能,并进行手术治疗,以做出病理诊断、恢复解剖结构并防止气胸患者复发。
{"title":"A surgical series on endometriosis-related diaphragmatic hernia.","authors":"Antonio Bobbio, Lorenzo Gherzi, Francesco Tormen, Antoine Sion, Mathilde Prieto, Elisa Daffre, Ludovic Fournel, Marco Alifano","doi":"10.1007/s11748-024-02016-y","DOIUrl":"10.1007/s11748-024-02016-y","url":null,"abstract":"<p><strong>Background: </strong>Thoracic endometriosis syndrome gives rise to various clinical and radiological manifestations. We reviewed the records of patients operated for intrathoracic migration of abdominal viscera through a diaphragmatic hernia secondary to thoracic endometriosis.</p><p><strong>Methods: </strong>We retrospectively reviewed the single-center prospective collected database of all patients operated for thoracic endometriosis during the twenty years. All cases in which an abdominal organ was found to be herniated into the thoracic cavity were retrieved. Clinical and pathological data are presented and analyzed.</p><p><strong>Results: </strong>Twenty women of median age 36 (range 25-58) years were operated for endometriosis-related diaphragmatic hernia. The hernia was diagnosed concomitantly with endometriosis-related pneumothorax in 13 cases and during the exploration of catamenial thoracic pain in seven cases. There were 18 cases on the right side and two cases on the left side. The median diameter of the hernia was 8 cm (2.5-20 cm). In seventeen cases, the hernia was repaired by direct suture, and in three cases a heterologous prosthesis was positioned. At follow-up, two patients had an episode of recurrent pneumothorax.</p><p><strong>Conclusions: </strong>Diaphragmatic hernia should be ruled out in the presence of endometriosis-related pneumothorax or catamenial thoracic pain. Surgery is indicated to make a pathological diagnosis, restore anatomy, and prevent recurrence in patients presenting with pneumothorax.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"668-673"},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140093731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
General Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1